Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elizabeth Sugar, PhD
Johns Hopkins University
Principal Investigator - Nirupama Putcha
Johns Hopkins School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
Michael WellsNot, yet, recruiting - Not, yet, recruiting
- University of San Francisco
San Francisco, California, United States
Stephanie ChristensonNot, yet, recruiting - National Jewish Health
Denver, Colorado, United States
Barry MakeNot, yet, recruiting - University of Florida
Jacksonville, Florida, United States
Vandana SeeramNot, yet, recruiting - Not, yet, recruiting
- Rush University Medical Center
Chicago, Illinois, United States
James MoyNot, yet, recruiting - University of Illinois at Chicago
Chicago, Illinois, United States
Lynn GeraldNot, yet, recruiting - University of Iowa
Iowa City, Iowa, United States
Alejandro ComellasNot, yet, recruiting - Not, yet, recruiting
- Johns Hopkins University
Baltimore, Maryland, United States
Niru PutchaRecruiting - University of Michigan
Ann Arbor, Michigan, United States
MeiLan HanNot, yet, recruiting - Henry Ford Health
Detroit, Michigan, United States
Alan BaptistNot, yet, recruiting - Columbia University
New York, New York, United States
Emily DiMangoNot, yet, recruiting - Cornell University
New York, New York, United States
Robery KanerNot, yet, recruiting - Mount Sinai, Icahn School of Medicine
New York, New York, United States
Linda RogersNot, yet, recruiting - Duke University Medical Center
Durham, North Carolina, United States
Loretta QueNot, yet, recruiting - Not, yet, recruiting
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Frank SciurbaNot, yet, recruiting - Vanderbilt University Medical Center
Nashville, Tennessee, United States
Katherine CahillNot, yet, recruiting - Baylor College of Medicine
Houston, Texas, United States
Nicola HananiaNot, yet, recruiting - University of Vermont
Colchester, Vermont, United States
Anne DixonNot, yet, recruiting - Pacific Northwest Airways - Va Puget Sound Healthcare System, Seattle
Seattle, Washington, United States
Laura FreemsterNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Feb 2026
- Primary completion
- 31 Jan 2031
- Completion
- 31 May 2031
- Last update posted
- 17 Feb 2026
- Registered enrollment
- 334
- Registry id
- NCT07059091
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.